tradingkey.logo

Allurion Technologies Inc

ALUR
1.080USD
-0.020-1.82%
收盘 02/09, 16:00美东报价延迟15分钟
1.84M总市值
亏损市盈率 TTM

Allurion Technologies Inc

1.080
-0.020-1.82%

关于 Allurion Technologies Inc 公司

Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.

Allurion Technologies Inc简介

公司代码ALUR
公司名称Allurion Technologies Inc
上市日期Mar 29, 2021
CEOGaur (Shantanu)
员工数量134
证券类型Ordinary Share
年结日Mar 29
公司地址11 Huron Dr Ste 200
城市NATICK
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编01760
电话15086474000
网址https://www.allurion.com/en
公司代码ALUR
上市日期Mar 29, 2021
CEOGaur (Shantanu)

Allurion Technologies Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
62.03K
-16000.00%
Mr. Larson Douglas Hudson
Mr. Larson Douglas Hudson
Independent Director
Independent Director
1.21K
+604.00%
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Dr. Ram Chuttani
Dr. Ram Chuttani
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Mr. Michael Davin
Mr. Michael Davin
Independent Director
Independent Director
--
--
Mr. Nicholas Sheridan (Nick) Lewin
Mr. Nicholas Sheridan (Nick) Lewin
Independent Director
Independent Director
--
--
Mr. Mike Cavanaugh
Mr. Mike Cavanaugh
Investor Relations
Investor Relations
--
--
Mr. Keith Johns
Mr. Keith Johns
Independent Director
Independent Director
--
--
Mr. R. Jason Richey
Mr. R. Jason Richey
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
62.03K
-16000.00%
Mr. Larson Douglas Hudson
Mr. Larson Douglas Hudson
Independent Director
Independent Director
1.21K
+604.00%
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Dr. Ram Chuttani
Dr. Ram Chuttani
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Mr. Michael Davin
Mr. Michael Davin
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
All other countries
941.00K
35.40%
Egypt (Country)
450.00K
16.93%
Italy
418.00K
15.73%
Spain
282.00K
10.61%
Argentina
272.00K
10.23%
其他
295.00K
11.10%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 2月1日 周日
更新时间: 2月1日 周日
持股股东
股东类型
持股股东
持股股东
占比
RTW Investments L.P.
47.98%
Leavitt Equity Partners III LP
3.77%
Armistice Capital LLC
1.51%
Lunt Capital Management Inc
1.36%
Romulus Capital Management, LLC
1.33%
其他
44.06%
持股股东
持股股东
占比
RTW Investments L.P.
47.98%
Leavitt Equity Partners III LP
3.77%
Armistice Capital LLC
1.51%
Lunt Capital Management Inc
1.36%
Romulus Capital Management, LLC
1.33%
其他
44.06%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
48.42%
Corporation
4.83%
Investment Advisor
3.06%
Hedge Fund
1.63%
Individual Investor
1.53%
Venture Capital
1.43%
其他
39.09%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
69
6.70M
54.55%
+3.08M
2025Q3
70
3.18M
46.56%
+1.57K
2025Q2
85
3.18M
48.45%
-269.85K
2025Q1
86
1.95M
28.76%
+237.16K
2024Q4
84
752.22K
40.38%
-48.13K
2024Q3
168
830.35K
127.59%
-73.34K
2024Q2
179
581.38K
156.78%
+113.95K
2024Q1
186
467.42K
172.37%
-2.84M
2023Q4
188
468.03K
181.14%
+55.07K
2023Q3
189
413.41K
181.62%
-47.54K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
RTW Investments L.P.
5.89M
63.6%
+3.35M
+131.71%
Nov 12, 2025
Leavitt Equity Partners III LP
462.76K
5%
+296.10K
+177.66%
Feb 19, 2025
Armistice Capital LLC
185.00K
2%
-206.64K
-52.76%
Jun 30, 2025
Romulus Capital Management, LLC
163.14K
1.76%
--
--
Oct 31, 2025
Compute Health Sponsor LLC
130.51K
1.41%
--
--
Oct 31, 2025
The Vanguard Group, Inc.
56.18K
0.61%
+6.82K
+13.81%
Sep 30, 2025
Gupta (Krishna K.)
76.18K
0.82%
+3.12K
+4.27%
Oct 31, 2025
Gaur (Shantanu)
62.03K
0.67%
-16.00K
-20.50%
Oct 31, 2025
Olayan Investments Company Establishment
49.70K
0.54%
--
--
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0%
Janus Henderson Small Cap Growth Alpha ETF
0%
iShares Micro-Cap ETF
占比0%
Janus Henderson Small Cap Growth Alpha ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
公告日期
除权除息日
类型
比率
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
KeyAI